Inventor · disambiguated record
Biao Xi
Also filed as: XI BIAO
20 granted patents·5 pending applications·161 citations·filing 2005–2023
95Inventor score
Files withACEA BIOSCIENCES INC14AGILENT TECHNOLOGIES INC4ACEA THERAPEUTICS INC2WANG XIAOBO2AN HAOYUN1
Top patents by PatentIndex Score
25 records- 0197US10012636B2Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolutionACEA BIOSCIENCES INC·Filed 2017·Granted Jul 3, 2018·13 cites·13 claims
- 0296US10533985B2Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolutionACEA BIOSCIENCES INC·Filed 2018·Granted Jan 14, 2020·7 cites·20 claims
- 0395US9612234B2Data analysis of impedance-based cardiomyocyte-beating signals as detected on real-time cell analysis (RTCA) cardio instrumentsLI NAN·Filed 2011·Granted Apr 4, 2017·24 cites·18 claims
- 0494US9709548B2Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolutionWANG XIAOBO·Filed 2009·Granted Jul 18, 2017·19 cites·24 claims
- 0593US9464089B2Heterocyclic compounds and uses thereofACEA BIOSCIENCES INC·Filed 2014·Granted Oct 11, 2016·12 cites·19 claims
- 0691US9920074B2Heterocyclic compounds and uses thereofACEA BIOSCIENCES INC·Filed 2016·Granted Mar 20, 2018·6 cites·21 claims
- 0790US10596174B2Pyrrolopyrimidine compounds as inhibitors of protein kinasesACEA BIOSCIENCES INC·Filed 2017·Granted Mar 24, 2020·4 cites·7 claims
- 0890US9763949B2EGFR modulators and uses thereofACEA BIOSCIENCES INC·Filed 2015·Granted Sep 19, 2017·8 cites·32 claims
- 0990US8685988B2EGFR modulators and uses thereofACEA BIOSCIENCES INC·Filed 2013·Granted Apr 1, 2014·11 cites·5 claims
- 1090US8252822B2Heterocyclic compounds and uses as anticancer agentsAN HAOYUN·Filed 2008·Granted Aug 28, 2012·24 cites·9 claims
- 1189US9034885B2EGFR modulators and uses thereofACEA BIOSCIENCES INC·Filed 2013·Granted May 19, 2015·11 cites·23 claims
- 1289US2024210379A1Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolutionAGILENT TECHNOLOGIES INC·Filed 2023·Application pending·0 cites
- 1388US11007197B2EGFR modulators and uses thereofACEA THERAPEUTICS INC·Filed 2019·Granted May 18, 2021·2 cites·18 claims
- 1485US11906508B2Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolutionAGILENT TECHNOLOGIES INC·Filed 2022·Granted Feb 20, 2024·0 cites·30 claims
- 1584US10449196B2EGFR modulators and uses thereofACEA BIOSCIENCES INC·Filed 2017·Granted Oct 22, 2019·3 cites·19 claims
- 1684US9586965B2Pyrrolo[2,3-d]pyrimidine compounds as inhibitors of protein kinasesACEA BIOSCIENCES INC·Filed 2013·Granted Mar 7, 2017·8 cites·30 claims
- 1783US10551371B2System and method for monitoring cardiomyocyte beating, viability and morphology and for screening for pharmacological agents which may induce cardiotoxicity or modulate cardiomyocyte functionWANG XIAOBO·Filed 2010·Granted Feb 4, 2020·4 cites·21 claims
- 1882US2022291191A1Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolutionAGILENT TECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 1980US10562918B2Heterocyclic compounds and uses thereofACEA BIOSCIENCES INC·Filed 2018·Granted Feb 18, 2020·3 cites·14 claims
- 2075US10799504B2Heterocyclic compounds and uses as anticancer agentsACEA BIOSCIENCES INC·Filed 2013·Granted Oct 13, 2020·2 cites·8 claims
- 2174US11360072B2Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolutionAGILENT TECHNOLOGIES INC·Filed 2020·Granted Jun 14, 2022·0 cites·20 claims
- 2267US11612602B2Heterocyclic compounds and uses as anticancer agentsACEA THERAPEUTICS INC·Filed 2020·Granted Mar 28, 2023·0 cites·20 claims
- 2364US2020278339A1System and method for monitoring cardiomyocyte beating, viability and morphology and for screening for pharmacological agents which may induce cardiotoxicity or modulate cardiomyocyte functionACEA BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 2457US2017205391A1Data analysis of cells undergoing excitation contraction coupling as detected on real-time cell analysis (rtca) instrumentsACEA BIOSCIENCES INC·Filed 2017·Application pending·0 cites
- 2533US2008207538A1Enhanced Production of Functional Proteins From Defective GenesLAWRENCE DAVID S·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Biao Xi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →